219 related articles for article (PubMed ID: 12385237)
1. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
2. [Expression of TMP Fc in Pichia pastoris and identification of its biological activity].
Ye XZ; Guo Q; Li C; Liu FY; Cheng DS
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):25-9. PubMed ID: 16108484
[TBL] [Abstract][Full Text] [Related]
3. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris.
Zhiyi H; Wenshan L; Wenze Z; Ning D; Chi Z; Kenan Y; Ping W; Qianqian W; Qing Z
J Biochem; 2007 Jul; 142(1):17-24. PubMed ID: 17517790
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.
Abina MA; Tulliez M; Duffour MT; Debili N; Lacout C; Villeval JL; Wendling F; Vainchenker W; Haddada H
J Immunol; 1998 May; 160(9):4481-9. PubMed ID: 9574554
[TBL] [Abstract][Full Text] [Related]
5. Peptide agonists of the thrombopoietin receptor.
Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells.
Erben U; Thiel E; Notter M
Cancer Res; 1999 Jun; 59(12):2924-30. PubMed ID: 10383156
[TBL] [Abstract][Full Text] [Related]
7. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in man.
de Serres M; Ellis B; Dillberger JE; Rudolph SK; Hutchins JT; Boytos CM; Weigl DL; DePrince RB
Stem Cells; 1999; 17(4):203-9. PubMed ID: 10437983
[TBL] [Abstract][Full Text] [Related]
9. [Eukaryotic expression of human LIGHT-Fc chimeric molecule and its anti-tumor activity].
Huang G; Bai Y; Jiang M; Li WL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):499-502. PubMed ID: 15169669
[TBL] [Abstract][Full Text] [Related]
10. Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein.
Cox GN; Smith DJ; Carlson SJ; Bendele AM; Chlipala EA; Doherty DH
Exp Hematol; 2004 May; 32(5):441-9. PubMed ID: 15145212
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and characterization of human recombinant thrombopoietin in Chinese hamster ovary cells.
Kaszubska W; Zhang H; Patterson RL; Suhar TS; Uchic ME; Dickinson RW; Schaefer VG; Haasch D; Janis RS; DeVries PJ; Okasinski GF; Meuth JL
Protein Expr Purif; 2000 Mar; 18(2):213-20. PubMed ID: 10686152
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
14. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
[TBL] [Abstract][Full Text] [Related]
16. Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.
Folman CC; von dem Borne AE; Rensink IH; Gerritsen W; van der Schoot CE; de Haas M; Aarden L
Thromb Haemost; 1997 Oct; 78(4):1262-7. PubMed ID: 9364995
[TBL] [Abstract][Full Text] [Related]
17. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
Zang W; Wei X; Wang S; Wang D
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):128-31. PubMed ID: 11877062
[TBL] [Abstract][Full Text] [Related]
18. Fusion protein of CDR mimetic peptide with Fc inhibit TNF-alpha induced cytotoxicity.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2006 Feb; 43(6):660-6. PubMed ID: 15878201
[TBL] [Abstract][Full Text] [Related]
19. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
20. Expression of soluble recombinant TGF-beta type II receptor fused with the Fc portion of human IgG1 (sTbetaRII-Fc) in NS0 cells.
Kwiatkowska EP; Kazimierczak U; Mackiewicz A; Kowalczyk DW
Acta Biochim Pol; 2006; 53(2):361-9. PubMed ID: 16733563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
